Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort
1 other identifier
observational
100
1 country
1
Brief Summary
In the present study, the severity of recurrent laryngeal nerve injury (RLNI) and hypocalcemia (H) will be followed-up and the probable interrelation between them will be proposed considering the clinical situation of patients, e.g. improvement in hypocalcemia also make a positive effect on voice? (any objective sign? Ca? PTH?), return of voice is parallel with the improvement in hypocalcemia? Postoperative calcium (Ca), parathyroid hormone (PTH), regular vocal cord evaluations by ear-nose-throat (ENT) exams, deterioration-stability-improvement of clinical symptoms regarding both Ca metabolism and vocal cord function will be noted at regular intervals (postoperative day 1-3-first, weekly control/first month, monthly/first 6-month, 3-monthly/6-12 months) at outpatient controls. Serum Ca, PTH, ENT evaluation of vocal cords-noted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2020
CompletedStudy Start
First participant enrolled
May 15, 2020
CompletedFirst Posted
Study publicly available on registry
May 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedMay 21, 2020
May 1, 2020
1 year
May 15, 2020
May 15, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
s/p TT- normal (no complication)
TT: total thyroidectomy
June 01, 2020-June 01, 2021
s/p TT+VCP
VCP: vocal cord paralysis
June 01, 2020-June 01, 2021
s/p TT+H
H: hypocalcemia
June 01, 2020-June 01, 2021
s/p TT+VCP+H
Any improvement recorded? VCP? H? vice versa
June 01, 2020-June 01, 2021
Secondary Outcomes (1)
Improvement in vocal cord function /serum calcium
June 01, 2020-June 01, 2021
Study Arms (4)
Control, s/p TT, without complication
Control (status/post-s/p total thyroidectomy-TT, without complication- demographics and BMI matched)
Experimental, s/p TT with only VCP
Experimental (s/p TT, with only vocal cord paralysis-VCP, uni or bilateral)
Experimental, s/p TT with only H
Experimental (s/p TT, with only hypocalcemia-H, transient or permanent)
Experimental, s/p TT with both VCP+H
Experimental (s/p TT, with both vocal cord paralysis-VCP and hypocalcemia-H); Subgroups: 4.1. VCP (Permanent) + H (Permanent) 4.2. VCP (Transient) + H (Transient) 4.3. VCP (Permanent) + H (Transient) 4.4. VCP (Transient) + H (Permanent) Please answer: * Improvement in hypocalcemia also make a positive effect on voice? (any objective sign? Ca? PTH?) * Return of voice is parallel with the improvement in hypocalcemia? (any objective sign? Ca? PTH?
Interventions
Patients with thyroid diseases either benign (e.g. multinodular goitre) or malign (e.g. thyroid carcinoma) will be prepared for total thyroidectomy procedure and will be enrolled.
Eligibility Criteria
Patients with benign or malign thyroid diseases, eligable for total thyroidectomy
You may qualify if:
- Patients with total thyroidectomy indication, for either benign (e.g. multinodular goitre) or malign (e.g. thyroid carcinoma) thyroid disease
- \>17 year-old
- Available for close follow-ups at outpatient clinic
- Available for close vocal cord exams
You may not qualify if:
- Patients with recurrent thyroid disease (benign/malign), prepared for a second operation
- Preferance of thyroid surgery other than total thyroidectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Umraniye Education and Research Hospital, Health Sciences University
Istanbul, 34764, Turkey (Türkiye)
Related Publications (2)
Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019 Apr;13(Suppl 1):S31-S34. doi: 10.4103/sja.SJA_543_18.
PMID: 30930717RESULTGiulea C, Enciu O, Toma EA, Calu V, Miron A. The Tubercle of Zuckerkandl is Associated with Increased Rates of Transient Postoperative Hypocalcemia and Recurrent Laryngeal Nerve Palsy After Total Thyroidectomy. Chirurgia (Bucur). 2019 Sept-Oct;114(5):579-585. doi: 10.21614/chirurgia.114.5.579.
PMID: 31670633RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sema YUKSEKDAG, MD
Instructor in General Surgery
- STUDY CHAIR
Ethem UNAL, MD, PhD, USMLE & IFSO-Certified, Board CSS
Assoc. Professor of General Surgery and Surgical Oncology
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, USMLE & IFSO-Certified, BCSS, Associated Professor of General Surgery and Surgical Oncology
Study Record Dates
First Submitted
May 15, 2020
First Posted
May 21, 2020
Study Start
May 15, 2020
Primary Completion
June 1, 2021
Study Completion
June 1, 2021
Last Updated
May 21, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- From June 01, 2020, for 6 months
- Access Criteria
- Contact to drethemunal@gmail.com
Study is open to high-volume INTERNATIONAL endocrine surgery centers, eager to join to present STROBE compatible observational study Available upon email requests@drethemunal@gmail.com